Adaptive Biotechnologies Corporation

Healthcare

NASDAQ:ADPT · NASDAQ Global Select

Market Cap $2.82B Beta 2.15 P/E (TTM) -55.1

$17.60 -6.03%

-$1.13 today

52W Low $9.96High $20.76

Vol 2.96M · Avg 1.96M

EPS (TTM)-$0.32

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+70.54%

Period High

$20.46

Period Low

$10.14

Latest

$17.60

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Legend Biotech Corporation

NASDAQ:LEGN

$6.63B

Cidara Therapeutics, Inc.

CDTX

$5.61B

Scholar Rock Holding Corporation

NASDAQ:SRRK

$5.29B

Catalyst Pharmaceuticals, Inc.

NASDAQ:CPRX

$3.84B

Beam Therapeutics Inc.

NASDAQ:BEAM

$2.99B

Tarsus Pharmaceuticals, Inc.

NASDAQ:TARS

$2.67B

Disc Medicine, Inc.

NASDAQ:IRON

$2.60B

IDEAYA Biosciences, Inc.

NASDAQ:IDYA

$2.55B

Zai Lab Limited

NASDAQ:ZLAB

$1.92B

Mineralys Therapeutics, Inc.

NASDAQ:MLYS

$1.57B

What is the latest ADPT filing?

The latest filing shown is 8-K dated Jun 9, 2026.

How many recent filings does ADPT have?

Intrinsic Alpha currently shows 20 recent filings for ADPT.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.